INR 883.4
(2.51%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 332.52 Million INR | -41.34% |
2022 | 566.87 Million INR | 35.34% |
2021 | 418.86 Million INR | 34.93% |
2020 | 310.42 Million INR | 16.86% |
2019 | 265.64 Million INR | 0.96% |
2018 | 263.11 Million INR | 7.6% |
2017 | 244.52 Million INR | -7.49% |
2016 | 264.3 Million INR | 31.98% |
2015 | 200.26 Million INR | 16.03% |
2014 | 172.59 Million INR | 23.62% |
2013 | 139.62 Million INR | 15.96% |
2012 | 120.41 Million INR | 0.0% |
2010 | 104.9 Million INR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 56.89 Million INR | 277.69% |
2023 FY | 332.52 Million INR | -41.34% |
2023 Q4 | 79.32 Million INR | -9.05% |
2023 Q1 | 149.61 Million INR | -7.43% |
2023 Q2 | 204.23 Million INR | 36.5% |
2023 Q3 | 87.21 Million INR | -57.3% |
2022 Q3 | 135.27 Million INR | -12.6% |
2022 FY | 566.87 Million INR | 35.34% |
2022 Q1 | 115.18 Million INR | 97.73% |
2022 Q2 | 154.78 Million INR | 34.38% |
2022 Q4 | 161.63 Million INR | 19.48% |
2021 Q1 | 114.48 Million INR | 73.32% |
2021 FY | 418.86 Million INR | 34.93% |
2021 Q4 | 58.25 Million INR | -53.53% |
2021 Q3 | 125.36 Million INR | 3.81% |
2021 Q2 | 120.75 Million INR | 5.48% |
2020 FY | 310.42 Million INR | 16.86% |
2020 Q1 | 59.06 Million INR | 10.65% |
2020 Q2 | 94.51 Million INR | 60.02% |
2020 Q3 | 90.79 Million INR | -3.94% |
2020 Q4 | 66.05 Million INR | -27.25% |
2019 FY | 265.64 Million INR | 0.96% |
2019 Q4 | 53.37 Million INR | -25.87% |
2019 Q2 | 73.39 Million INR | 9.75% |
2019 Q1 | 66.86 Million INR | 36.26% |
2019 Q3 | 72 Million INR | -1.89% |
2018 Q4 | 49.07 Million INR | -23.73% |
2018 FY | 263.11 Million INR | 7.6% |
2018 Q3 | 64.34 Million INR | 0.0% |
2017 FY | 244.52 Million INR | -7.49% |
2016 Q1 | 60.76 Million INR | 0.0% |
2016 FY | 264.3 Million INR | 31.98% |
2015 FY | 200.26 Million INR | 16.03% |
2014 FY | 172.59 Million INR | 23.62% |
2013 FY | 139.62 Million INR | 15.96% |
2012 FY | 120.41 Million INR | 0.0% |
2010 FY | 104.9 Million INR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Biocon Limited | 91.73 Billion INR | 99.638% |
Blue Jet Healthcare Limited | 3.15 Billion INR | 89.474% |
Concord Biotech Limited | 7.56 Billion INR | 95.604% |
Dishman Carbogen Amcis Limited | 4.9 Billion INR | 93.219% |
Jubilant Ingrevia Limited | 9.16 Billion INR | 96.372% |
Lyka Labs Limited | 145.95 Million INR | -127.833% |
Panacea Biotec Limited | 1.42 Billion INR | 76.709% |
Piramal Pharma Limited | 24.47 Billion INR | 98.641% |
SMS Lifesciences India Limited | 329.57 Million INR | -0.895% |
Supriya Lifescience Limited | 2.65 Billion INR | 87.46% |
Syngene International Limited | 12.43 Billion INR | 97.327% |
TAKE Solutions Limited | 183.42 Million INR | -81.293% |